Abstracts - faqs.org

Abstracts

Business

Search abstracts:
Abstracts » Business

Diminishing role of mezzanine finance

Article Abstract:

The provision of mezzanine finance in the UK reached a peak in 1989 at around 870 million pounds sterling. It became less important during 1990 to 1995 with 826 million pounds sterling worth of this finance provided. Mezzanine finance is classed as lying between debt and equity and allows businesses to be acquired at higher prices with no dilution affecting the equity return. Mezzanine finance has become less important as equity and bank debt have become more easily available.

Author: Temple, Peter
Publisher: FT Business
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 1996
Mezzanine financing

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Players fall into many camps

Article Abstract:

UK management buy-out (MBO) players include CINVen and Prudential. Investors using funds from other investors have to pay attention to returns from investments in MBOs. 3i has supported a wide variety of transactions such as an MBO involving Morse Group. Candover is a well-established backer of MBOs and it was involved in a Shepperton Studios MBO in 1995, in addition to an MBO at Albion. HSBC Private Equity's deals have included Gallaher, a subsidiary of American Brands.

Author: Temple, Peter
Publisher: FT Business
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 1996
Management buyouts

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: United Kingdom, Venture capital companies
Similar abstracts:
  • Abstracts: Private equity for the private investor. VCTS splutter into life
  • Abstracts: Private equity: sector shows signs of increasing maturity. Private equity: political uncertainty concentrates minds
  • Abstracts: Sink or swim? MBO wins friends in the regions. Institutional investors
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.